| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $462,001 ) |
| 2024 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 4 | 5/16/2024 | NON-COMPETING CONTINUATION | $462,001 |
|
| Issue Date FY: 2023 ( Subtotal = $481,250 ) |
| 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 3 | 5/1/2023 | NON-COMPETING CONTINUATION | $481,250 |
|
| Issue Date FY: 2022 ( Subtotal = $481,250 ) |
| 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 2 | 4/21/2022 | NON-COMPETING CONTINUATION | $481,250 |
|
| Issue Date FY: 2021 ( Subtotal = $481,250 ) |
| 2021 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 1 | 7/15/2021 | NEW | $481,250 |
|
|